Infliximab (IFX) is a chimeric IgG1 monoclonal antibody against tumor necrosis factor alpha (TNFα) used in a wide range of inflammatory diseases [1], such as inflammatory bowel disease and spondyloarthropathies. Here, TNF is linked to spondyloarthropathy.